PITTSBURGH, May 03, 2021 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, announced today the appointment of Andy Orth as ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Laurent Goux as the general manager of Europe for Krystal ...
PITTSBURGH, May 03, 2021 (GLOBE NEWSWIRE) -- Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, announced today the appointment of Andy Orth as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback